1. Introduction {#sec0005}
===============

The duration of the QT interval is one of the ventricular repolarization markers that can predict malignant arrhythmias in several diseases, including hypertension.[@bib0170] The QT interval is considered as one of the predictors of the risk of both coronary events and cardiovascular death in patients with hypertension.[@bib0175] In patients with uncomplicated hypertension, a prolonged corrected QT (QTc) interval is accompanied with a twofold increase in the risk of cardiac events after adjusting the other risk factors.[@bib0180] In elderly subjects the duration of the QT interval is considered as a prognostic marker as Dimopoulos et al. found a high blood pressure (systolic and diastolic), and cardiac arrhythmias are associated with a higher value of the QTc dispersion.[@bib0185] Prolonged ventricular repolarization found to be a risk factor of cardiac morbidity and mortality in patients with resistant hypertension after adjusting the systolic blood pressure while in pregnancy induced hypertension, the duration of the QT interval found to be within the normal range of the healthy women.[@bib0190] In hypertension associated with obesity, the duration of QTc interval is prolonged and tended to be decreased after blood pressure control and weight loss.[@bib0195] Antihypertensive drugs (angiotensin converting enzyme inhibitors and angiotensin receptor blockers) reduced the duration of QT interval due to their effects on the left ventricular mass which increases in hypertension.[@bib0200], [@bib0205], [@bib0210] Beta-adrenoceptor blockers may also reduce the duration of the QT interval in a dose-dependent manner without having any effect on the blood pressure[@bib0215], [@bib0220] while calcium channel blockers (dihydropyridine) do not exert a beneficial effect on QT interval.[@bib0225] High ceiling diuretics and thiazides may prolong QT interval due to electrolyte disturbances[@bib0230] while potassium sparing diuretics shortened the QTc interval.[@bib0235] The duration of JT interval is also a marker of ventricular repolarization and it is of more benefit than QT interval because the Bazett\'s formula of QTc exaggerates heart rate-dependency of ventricular repolarization intervals.[@bib0240] Li et al. demonstrated the association between metabolic syndrome and prolonged QT and JT intervals and these intervals significantly correlated with the number of the metabolic derangement.[@bib0245] Hypertensive patients treated with different antihypertensive drugs may have abnormal cardiac electrophysiology, in addition, the status of blood pressure control may also influence the duration of ventricular repolarization. Therefore, this study aims to demonstrate the subclinical ventricular conduction defects in treating hypertensive patients taking in consideration the status of the blood pressure control.

2. Materials and methods {#sec0010}
========================

This cross-section study was performed at the Departments of Physiology and Pharmacology, College of Medicine, Al-Mustansiriya University, Baghdad, Iraq in accordance with the Declaration of Helsinki. The study protocol was approved by the Institutional Scientific Committee. The study included hypertensive patients who were followed up with a diagnosis of essential hypertension at the private clinics between January 1, 2014 and January 30, 2015. All patients provided informed consent to participate in the study. The criteria of inclusion were essential hypertension treated with antihypertensive drugs. The criteria of exclusion included secondary hypertension, diabetes mellitus, pregnancy, renal and hepatic failure. From each patient, the subjective data related to the current medical and the other associated illnesses were obtained. Each patient was examined clinically and the blood pressure was measured on sitting position. The mean of three readings of the blood pressure was taken. The mean arterial blood pressure was determined using the following equation: Mean arterial blood pressure (mmHg) = Diastolic + (1/3) pulse pressure. The pulse pressure is equal to systolic *minus* diastolic blood pressure.

Controlled hypertension was diagnosed as systolic and diastolic blood pressure \<140 mmHg and \<90 mmHg, respectively while a systolic and/or diastolic blood pressure ≥140 mmHg and/or 90 mmHg was diagnosed uncontrolled hypertension at the time of the current use of antihypertensive drugs.

Each participant is subjected to the electrocardiograph (ECG) investigation. Specifications of the ECG machine are: 12 standard leads, the sensitivity is 10 mm/mV, the record speed is 25 mm/s. The ECG records of patients who were in sinus rhythm are obtained. All ECG waveforms were verified by visual inspection.[@bib0250] The ECG record strips were scanned and the scanned picture was magnified by PC windows photo-viewer to zoom. From each ECG record strips, the following data were obtained: heart rate (beats/min); R-R interval (s); P-R interval (s); QRS wave duration (s); QTm (QT measured) interval (s); QTc (QT corrected) interval (s); JTm (JT measured) interval (s); JTc (JT corrected) interval (s) and JT index.

QTc (QT corrected) interval (s): it is calculated by using the following formulae[@bib0255]:$$\text{Bazett\ formula}(QT_{C}B) = QTm/\sqrt{RR}$$

The cutoff point of QTcB value is used according to Goldberg et al.[@bib0260] with a modification of children and adolescent age that instead of \<15 years, ≤18 year old is considered ([Table 1](#tbl0005){ref-type="table"}).

The JTm (s) was calculated by subtracting QRS complex duration from QT interval and the corrected (JTc) was calculated by subtracting of the duration of QRS complex from QTcB. The JT index = JTm (heart rate + 100)/518, and a cutoff value of ≥112 indicated a prolonged duration of ventricular repolarization in ventricular conduction defect.[@bib0265] A QT nomogram plot that developed by Chan et al., used to identify the patients who are vulnerable or at risk of developing cardiac arrhythmias.[@bib0270] The QT-nomogram plot represented a plot of heart rate against the QT interval and any point out of the curve indicated that the patient is vulnerable to cardiac arrhythmias.

A total number of 97 hypertensive patients (30 males and 67 females) were enrolled in this study. Seventeen of them have a blood pressure of less than 140 (systolic) and less than 90 (diastolic), and this group represented as controlled hypertension and assigned Group I. Eight patients have either high systolic, or diastolic or both and represented as uncontrolled hypertension and assigned Group II.

Six patients have a systolic blood pressure ≥140 mmHg and a diastolic blood pressure \<90 (Group IIA), 12 patients have a diastolic blood pressure ≥90 mmHg and a systolic blood pressure \<140 (Group IIB), and 62 patients have a systolic and diastolic blood pressure ≥140 and 90 mmHg respectively (Group IIC).

2.1. Statistical analysis {#sec0015}
-------------------------

The statistical analysis was performed by using SPSS v.20.0 for Windows (IBM Corp., Armonk, NY, USA). The results are expressed as a number and mean ± SD. The difference between percentage tests was used to compare categorical variables. The differences in means were analyzed by using the two tailed unpaired *t*-test and a simple correlation test was used to determine the relationship between hematological indices and the variables related to the mean blood pressure and the other metabolic derangement determinants. The level of statistical significance was set at *p* ≤ 0.05.

3. Results {#sec0020}
==========

[Table 1](#tbl0005){ref-type="table"} showed that there are insignificant variation in age and duration of hypertension between the groups. The habit of current smoking is observed in a significant high percent in Group II compared with Group I. Previous history of stroke and ischemic heart disease observed in a significant high frequency in Group II compared with Group I ([Table 2](#tbl0010){ref-type="table"}). Variability in the prescription of antihypertensive drugs observed in Group II compared with group I. At the time of entry, significant high systolic, diastolic, and both systolic and diastolic blood pressure observed in 6, 12, and 62 patients, respectively (Group II) compared with 17 out 97 patients were under control blood pressure ([Table 3](#tbl0015){ref-type="table"}) Accordingly the pulse pressure and the mean arterial blood pressures were significantly differed from the corresponding values of Group I. ([Table 3](#tbl0015){ref-type="table"}). There were no significant differences in the values of the electrocardiogram determinants between controlled hypertension (Group I) and uncontrolled hypertension (Group II) ([Table 4](#tbl0020){ref-type="table"}). Abnormal prolonged QTcB interval observed in 18 out of 80 (22.5%) patients of Group II compared with 4 out of 17 (23.5%) patients of Group I, the difference did not reach a significant level. The JT index value of ≥112 was observed in 20 out of 80 (25%) patients of Group II compared with 6 out of 17 (35.3%) patients of Group I, the difference did not reach a significant level ([Table 4](#tbl0020){ref-type="table"}). [Fig. 1](#fig0005){ref-type="fig"} shows that 8 patients (1 belonged to Group I and 7 belonged to Group II) were vulnerable to cardiac arrhythmias, the difference did not reach to the significant level (5.9% versus 8.8% respectively). [Fig. 2](#fig0010){ref-type="fig"} shows significant correlations between the QTcB interval with JT index in both Groups I and II. The coefficient factors were 0.841 and 0.742 for Groups I and II respectively. The frequency of borderline-pathological prolonged QTcB interval observed in 13 out of 43 patients using antihypertensive drugs in term of beta-adrenoceptors compared with 11 out of 55 patients not used these medications, the difference did not reach significant levels (30.2% versus 20% respectively) ([Table 5](#tbl0025){ref-type="table"}).

4. Discussion {#sec0025}
=============

The results of this study demonstrate prolonged QTcB interval and a higher JT index in patients with hypertension, whether controlled or uncontrolled and drugs that produce conduction defect as beta-adrenoceptors play a minor role. The results of this study point out that approximately a quarter of patients are at risk of cardiac arrhythmias as a result of a defect in ventricular repolarization. Measurement of QTcB and JT index considered as a good marker of assessment ventricular repolarization and variation of the ventricular repolarization may predispose to the malignant arrhythmias.[@bib0275] There is evidence that patients with QTc duration of ≥530 ms are at risk of cardiac arrest and sudden cardiac death.[@bib0280] Therefore, we can expect that a number of our patients are at risk of sudden cardiac death because of cardiac arrhythmias. It is important to mention here that genetic factor is the cause of the prolonged of the QTcB period in some patients, but it is unlikely to be the cause of about 25% of our patients.[@bib0285], [@bib0290], [@bib0295] The cause of prolonged QTcB interval in this study is acquired due to hypertension. Hypertension per se has an increased risk of arrhythmias due to an increase of dispersion of ventricular repolarization that resulted from left ventricular hypertrophy.[@bib0300], [@bib0305], [@bib0310] Previous studies reported that prolonged QTcB period is demonstrated in resistant hypertension and related to the systolic blood pressure, obesity and left ventricular mass.[@bib0315], [@bib0320] In this study the prolonged QTcB period is demonstrated in both controlled and uncontrolled hypertension. Acute myocardial ischemia that follows hypertension may be the cause of prolonged QTcB. In this study significant high number of uncontrolled hypertension had a history of chronic myocardial ischemia and it may be not a sole cause because there is non-significant difference in the electrocardiogram determinants between Group I and II was observed. A considerable number of patients who have a JT index ≥112 are reported in this study which indicated that those patients are at risk of sudden death. Zulqarnain et al. (2015) reported that prolonged JT is a predictor of mortality in a population using multivariate-adjusted Cox regression models.[@bib0325] Panikkath et al. found that the prolonged QT period is the only electrocardiograph interval irrespective of JT interval was significantly associated with sudden cardiac death.[@bib0330] This study demonstrates the significant correlation between QTCB and JT index in both controlled and uncontrolled hypertension indicated that the utility of JT index can be applied to detect the patients who are at risk of malignant arrhythmias. One group of the antihypertensive drugs that used in this study is beta-adrenoceptor blockers, which do not induce significant abnormality in electrocardiograph records compared with those without using beta-adrenoceptor blockers. Beta-adrenoceptor blockers in toxic dose, interfere with cardiac conduction system while in therapeutic dose have no effect on the electrocardiograph intervals.

4.1. Limitations {#sec0030}
----------------

One of the limitations of this study is the determination of electrocardiograph intervals in newly cases of hypertension before the administration of antihypertensive drugs. Small sample size of isolated hypertension is another limitation of the study.

5. Conclusion {#sec0035}
=============

We conclude that treated patients with hypertension presented with controlled or uncontrolled high blood pressure are at risk of cardiac arrhythmias due to the variability in the ventricular repolarization by the evidence of prolonged QTcB and JT index.
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![QT nomogram shows the patients who are vulnerable to cardiac arrhythmias represented by dots above the curve line of nomogram.](gr1){#fig0005}
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###### 

Cut-off value of QTcB according to age and gender.

Table 1

  ---------------------------------------------------------------------
  Category     Children and adolescent\   Adult male     Adult female
               \<18 years                                
  ------------ -------------------------- -------------- --------------
  Normal       \<0.44 s                   \<0.43 s       \<0.45 s

  Borderline   0.44--0.46 s               0.43--0.45 s   0.45--0.47 s

  Prolonged    \>0.46 s                   \>0.45 s       \>0.47 s
  ---------------------------------------------------------------------

###### 

Characteristics of the study.

Table 2

  Characteristics                   Controlled hypertension   Uncontrolled hypertension                
  --------------------------------- ------------------------- --------------------------- ------------ -------------------------------------------
  Gender (M:F)                      4:13                      1:5                         3:9          22:40
  Age (year)                        60.3 ± 6.4                62.8 ± 9.5                  59.4 ± 4.1   65.8 ± 8.4
  Duration of hypertension (year)   10.8 ± 4.3                13.0 ± 5.7                  12.0 ± 3.9   15.1 ± 5.1
  Current smoking                   4                         1                           5            39
  Previous history                                                                                     
   Hypertensive crisis              0                         0                           0            0
   Transient ischemic attack        0                         0                           0            6
   Migraine                         1                         0                           0            2
   Stroke                           2                         1                           3            33[\*\*](#tblfn0005){ref-type="table-fn"}
   Ischemic heart disease           4                         2                           4            25
  Current medications                                                                                  
   Lipid lowering agents            13                        6                           7            43
   ACEI                             6                         2                           1            19
   ARBs                             5                         3                           5            27
   Beta-blockers                    6                         3                           6            28
   Alpha-blockers                   4                         0                           3            7
   Thiazides                        4                         0                           2            10

The results are expressed as number and mean ± SD.

*p* = 0.008.

###### 

Blood pressure measurements.

Table 3

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Blood pressure (mmHg)   Group I\      Group IIA\                                          Group IIB\                                           Group IIC\
                          (*n* = 17)    (*n* = 6)                                           (*n* = 12)                                           (*n* = 62)
  ----------------------- ------------- --------------------------------------------------- ---------------------------------------------------- -----------------------------------------------------
  Systolic                125.3 ± 8.6   150.8 ± 15.0[\*](#tblfn0010){ref-type="table-fn"}   127.1 ± 6.6                                          159.9 ± 14.7[\*\*](#tblfn0015){ref-type="table-fn"}

  Diastolic               82.1 ± 2.5    80.8 ± 2.0                                          93.3 ± 4.9[\*\*](#tblfn0015){ref-type="table-fn"}    100.8 ± 8.7[\*\*](#tblfn0015){ref-type="table-fn"}

  Pulse                   43.2 ± 8.8    70.0 ± 15.5[\*](#tblfn0010){ref-type="table-fn"}    33.8 ± 8.0[\*](#tblfn0010){ref-type="table-fn"}      59.1 ± 14.5[\*\*](#tblfn0015){ref-type="table-fn"}

  Mean arterial           96.5 ± 3.4    104.1 ± 4.9[\*](#tblfn0010){ref-type="table-fn"}    104.6 ± 4.0[\*\*](#tblfn0015){ref-type="table-fn"}   120.5 ± 8.7[\*\*](#tblfn0015){ref-type="table-fn"}
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

The results are expressed as mean ± SD.

*p* \< 0.01 compared with corresponding value of Group I.

*p* \< 0.001 compared with corresponding value of Group I.

###### 

Analysis of electrocardiogram data.

Table 4

  ----------------------------------------------------------------------------------------------------------------------
  Electrocardiogram parameters   Controlled hypertension\   Uncontrolled hypertension\                   
                                 (*n* = 17)                 (*n* = 80)                                   
  ------------------------------ -------------------------- ---------------------------- --------------- ---------------
  Heart rate                     79.2 ± 16.4                90.3 ± 11.0                  75.4 ± 13.2     84.7 ± 17.7

  P-R interval (s)               0.152 ± 0.060              0.163 ± 0.050                0.147 ± 0.055   0.150 ± 0.035

  R-R interval (s)               0.762 ± 0.152              0.650 ± 0.096                0.788 ± 0.157   0.750 ± 0.263

  QRS complex duration (s)       0.065 ± 0.023              0.068 ± 0.033                0.080 ± 0.036   0.070 ± 0.025

  QTc m (s)                      0.365 ± 0.052              0.370 ± 0.045                0.362 ± 0.065   0.361 ± 0.066

  QTCB (s)                       0.423 ± 0.066              0.459 ± 0.041                0.410 ± 0.058   0.424 ± 0.064

   Normal range                  12                         2                            9               43

   Borderline range              1                          2                            1               5 (NS)

   Abnormal range                4                          2                            2               14 (NS)

  JTm (s)                        0.300 ± 0.045              0.302 ± 0.029                0.282 ± 0.043   0.290 ± 0.065

  JTc (s)                        0.368 ± 0.065              0.391 ± 0.027                0.330 ± 0.049   0.354 ± 0.065

  JT index                       103.62 ± 16.93             110.4 ± 6.4                  94.74 ± 11.54   102.7 ± 19.55

  JT index ≥112 (no.)            6                          2                            1               17 (NS)
  ----------------------------------------------------------------------------------------------------------------------

The results are expressed as mean ± SD. Non-significant difference between Group I and Group IIA, IIB, and IIC.

###### 

Distribution of patients with borderline-pathological prolonged QTcB interval in respect of using beta-adrenoceptor blockers.

Table 5

  --------------------------------------------------------------
  Determinant                 Group I\     Group II\         
                              (*n* = 17)   (*n* = 80)        
  --------------------------- ------------ ------------ ---- ---
  QTcB                                                       

   Borderline                 1            0            3    5

   Pathological (prolonged)   0            4            12   6

  JTI ≥112                    2            4            11   7
  --------------------------------------------------------------

The results are expressed as absolute number.
